Cargando…

Can N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Be Localized to an Individual Cell Type?

Hypofunction of N-methyl-D-aspartate glutamate receptors (NMDARs), whether caused by endogenous factors like auto-antibodies or mutations, or by pharmacological or genetic manipulations, produces a wide variety of deficits which overlap with—but do not precisely match—the symptom spectrum of schizop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bygrave, Alexei M., Kilonzo, Kasyoka, Kullmann, Dimitri M., Bannerman, David M., Kätzel, Dennis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881463/ https://www.ncbi.nlm.nih.gov/pubmed/31824347 http://dx.doi.org/10.3389/fpsyt.2019.00835

Ejemplares similares

Gene-Environment Interaction in a Conditional NMDAR-Knockout Model of Schizophrenia
por: Bygrave, Alexei M., et al.
Publicado: (2019)

Optogenetic induction of the schizophrenia-related endophenotype of ventral hippocampal hyperactivity causes rodent correlates of positive and cognitive symptoms
por: Wolff, Amy R., et al.
Publicado: (2018)

Hippocampal–prefrontal coherence mediates working memory and selective attention at distinct frequency bands and provides a causal link between schizophrenia and its risk gene GRIA1
por: Bygrave, Alexei M., et al.
Publicado: (2019)

Hippocampal Hyperactivity as a Druggable Circuit-Level Origin of Aberrant Salience in Schizophrenia
por: Kätzel, Dennis, et al.
Publicado: (2020)

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
por: Weickert, C S, et al.
Publicado: (2013)

Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia
por: Kim, Seong-Wook, et al.
Publicado: (2015)

Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia
por: Amato, Davide, et al.
Publicado: (2019)

Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801
por: Bygrave, A M, et al.
Publicado: (2016)

N-methyl d-aspartate receptor hypofunction reduces visual contextual integration
por: Schielke, Alexander, et al.
Publicado: (2021)

Sleep spindles across youth affected by schizophrenia or anti-N-methyl-D-aspartate-receptor encephalitis
por: Dimitriades, Maria E., et al.
Publicado: (2023)

N-Acetyl-Aspartate Level is Decreased in the Prefrontal Cortex in Subjects At-Risk for Schizophrenia
por: Mondino, Marine, et al.
Publicado: (2013)

Delayed-matching-to-position working memory in mice relies on NMDA-receptors in prefrontal pyramidal cells
por: Kilonzo, Kasyoka, et al.
Publicado: (2021)

Distinct contributions of GluA1-containing AMPA receptors of different hippocampal subfields to salience processing, memory and impulse control
por: Kilonzo, Kasyoka, et al.
Publicado: (2022)

Can Neurostimulation Prevent the Risk of Alzheimer's Disease in Elderly Individuals with Schizophrenia?
por: Sfera, Adonis
Publicado: (2013)

NMDAR Hypofunction Animal Models of Schizophrenia
por: Lee, Gloria, et al.
Publicado: (2019)

From Toxoplasmosis to Schizophrenia via NMDA Dysfunction: Peptide Overlap between Toxoplasma gondii and N-Methyl-d-Aspartate Receptors As a Potential Mechanistic Link
por: Lucchese, Guglielmo
Publicado: (2017)

Pharmacologically induced N‐methyl‐D‐aspartate receptor hypofunction impairs goal‐directed food seeking in rats
por: Ozawa, Takaaki, et al.
Publicado: (2021)

N-methyl-D-aspartate receptor hypofunction as a potential contributor to the progression and manifestation of many neurological disorders
por: Dong, Bin, et al.
Publicado: (2023)

Inhibitors of Endocannabinoids’ Enzymatic Degradation as a Potential Target of the Memory Disturbances in an Acute N-Methyl-D-Aspartate (NMDA) Receptor Hypofunction Model of Schizophrenia in Mice
por: Kruk-Slomka, Marta, et al.
Publicado: (2023)

Lack of redundancy between electrophysiological measures of long-range neuronal communication
por: Strahnen, Daniel, et al.
Publicado: (2021)

Drugs Based on NMDAR Hypofunction Hypothesis in Schizophrenia
por: Wu, Qiongqiong, et al.
Publicado: (2021)

The Emerging Role of Altered d-Aspartate Metabolism in Schizophrenia: New Insights From Preclinical Models and Human Studies
por: Errico, Francesco, et al.
Publicado: (2018)

Autoantibodies to the N-Methyl-D-Aspartate Receptor in Adolescents With Early Onset Psychosis and Healthy Controls
por: Engen, Kristine, et al.
Publicado: (2020)

Anti-N-Methyl-D-Aspartate-Receptor Encephalitis: A 10-Year Follow-Up
por: Meixensberger, Sophie, et al.
Publicado: (2020)

PM372. Functional change of serotonin 2C receptors in N-Methyl-D-aspartate (NMDA) receptor hypofunctional condition
por: Tsutsumi, Takahiro, et al.
Publicado: (2016)

Effects of Immune Activation during Early or Late Gestation on N-Methyl-d-Aspartate Receptor Measures in Adult Rat Offspring
por: Rahman, Tasnim, et al.
Publicado: (2017)

Anti-N-Methyl-d-Aspartate Receptor Encephalitis in a Patient with Alcoholism: A Rare Case Report
por: Li, Yangyang, et al.
Publicado: (2017)

Case Report: Cotard's Syndrome in Anti-N-methyl D-aspartate (NMDA) Receptor (Anti-NMDAR) Encephalitis
por: Taib, Nur Iwana Abdul, et al.
Publicado: (2022)

Understanding and Managing Cognitive Distortions in Individuals With Schizophrenia
por: Verma, Kamal K
Publicado: (2023)

Markers of muscarinic deficit for individualized treatment in schizophrenia
por: Stuke, Heiner
Publicado: (2023)

Human Autoantibodies Against N-Methyl-D-Aspartate Receptor Modestly Alter Dopamine D1 Receptor Surface Dynamics
por: Gréa, Hélène, et al.
Publicado: (2019)

Case Report: Anti-N-Methyl-D-Aspartate Receptor Encephalitis Manifesting With an Isolated Psychiatric Episode and Normal Ancillary Tests
por: Pavǎl, Denis, et al.
Publicado: (2022)

Absence of Excess Intra-Individual Variability in Retinal Function in People With Schizophrenia
por: Fradkin, Samantha I., et al.
Publicado: (2020)

Altered Excitatory-Inhibitory Balance in the NMDA-Hypofunction Model of Schizophrenia
por: Kehrer, Colin, et al.
Publicado: (2008)

NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia
por: Snyder, Melissa A., et al.
Publicado: (2013)

Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia
por: Nakazawa, Kazu, et al.
Publicado: (2017)

Molecular Basis of GABA Hypofunction in Adolescent Schizophrenia-Like Animals
por: Wang, Xiaodan, et al.
Publicado: (2021)

Chemical–genetic attenuation of focal neocortical seizures
por: Kätzel, Dennis, et al.
Publicado: (2014)

Self-Awareness Deficits of Cognitive Impairment in Individuals With Schizophrenia. Really?
por: Raffard, Stéphane, et al.
Publicado: (2020)

Dysregulated noradrenergic response is associated with symptom severity in individuals with schizophrenia
por: Pelegrino, Ana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r33q54vuc1920c2kl7jjgpv2m9